Exelixis Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript
Hello, this webcast presentation is for Bank of America clients only. If you are a member or representative of the press or media, please disconnect now. And now I would like to turn the call over to the moderator. Thank you, and have a good day.
Great. Thank you, and thank you, everybody, for joining us for our next company presentation at Bank of America's Annual Healthcare Conference. My name is Jason Gerberry, and I cover Specialty Pharma and Smid-Cap Biotech at BofA, and I'm pleased to be introducing Exelixis and CEO, Mike Morrissey. Exelixis is focused on oral small molecules for cancer and known for its development of CABOMETYX for both renal and liver cancer. And Mike, thank you so much for joining us today.
It's great to be here. Wish we were back in Vegas, like the old format, but this is working out great today. So thanks again for inviting us to
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
